Latest period
$32.1B
YoY change
+5.0%
5Y CAGR
+3.6%
Peak year (FY2025)
$29.4B
Latest annual
$29.4B
Total Assets history chart for Biogen (BIIB) from 2016 to 2025
Latest: $29.4B
Total Assets growth chart for Biogen (BIIB) from 2016 to 2025
Latest: +5.0%
Total Assets history table for Biogen (BIIB) from 1985 to 2025
| FY2025 | $29.4B | +5.0% | +$1.39B | ||
| FY2024 | $28B | +4.5% | +$1.2B | ||
| FY2023 | $26.8B | +9.3% | +$2.29B | ||
| FY2022 | $24.6B | +2.8% | +$677M | ||
| FY2021 | $23.9B | -3.0% | -$742M | ||
| FY2020 | $24.6B | -9.6% | -$2.62B | ||
| FY2019 | $27.2B | +7.7% | +$1.95B | ||
| FY2018 | $25.3B | +6.9% | +$1.64B | ||
| FY2017 | $23.7B | +3.4% | +$776M | ||
| FY2016 | $22.9B | +17.3% | +$3.37B | ||
| FY2015 | $19.5B | +36.2% | +$5.19B | ||
| FY2014 | $14.3B | +20.7% | +$2.45B | ||
| FY2013 | $11.9B | +17.1% | +$1.73B | ||
| FY2012 | $10.1B | +11.9% | +$1.08B | ||
| FY2011 | $9.05B | +11.8% | +$957M | ||
| FY2010 | $8.09B | -5.4% | -$459M | ||
| FY2009 | $8.55B | +0.9% | +$72.9M | ||
| FY2008 | $8.48B | -1.7% | -$150M | ||
| FY2007 | $8.63B | +0.9% | +$76M | ||
| FY2006 | $8.55B | +2.2% | +$186M | ||
| FY2005 | $8.37B | -8.7% | -$799M | ||
| FY2004 | $9.17B | -3.6% | -$338M | ||
| FY2003 | $9.5B | +373.5% | +$7.5B | ||
| FY2002 | $2.01B | +16.6% | +$286M | ||
| FY2001 | $1.72B | +20.2% | +$289M | ||
| FY2000 | $1.43B | +12.0% | +$154M | ||
| FY1999 | $1.28B | +38.2% | +$353M | ||
| FY1998 | $925M | +13.6% | +$111M | ||
| FY1997 | $814M | +28.2% | +$179M | ||
| FY1996 | $635M | +35.2% | +$165M | ||
| FY1995 | $469M | +24.2% | +$91.3M | ||
| FY1994 | $378M | +5.8% | +$20.9M | ||
| FY1993 | $357M | +14.7% | +$45.8M | ||
| FY1992 | $311M | +23.0% | +$58.1M | ||
| FY1991 | $253M | +59.7% | +$94.6M | ||
| FY1990 | $159M | +9.2% | +$13.3M | ||
| FY1989 | $145M | +79.5% | +$64.3M | ||
| FY1988 | $80.9M | +0.2% | +$200K | ||
| FY1987 | $80.7M | -20.0% | -$20.2M | ||
| FY1986 | $101M | +17.6% | +$15.1M | ||
| FY1985 | $85.8M | — | — |
- FY2025$29.4B+5.0%
- FY2024$28B+4.5%
- FY2023$26.8B+9.3%
- FY2022$24.6B+2.8%
- FY2021$23.9B-3.0%
- FY2020$24.6B-9.6%
- FY2019$27.2B+7.7%
- FY2018$25.3B+6.9%
- FY2017$23.7B+3.4%
- FY2016$22.9B+17.3%
- FY2015$19.5B+36.2%
- FY2014$14.3B+20.7%
- FY2013$11.9B+17.1%
- FY2012$10.1B+11.9%
- FY2011$9.05B+11.8%
- FY2010$8.09B-5.4%
- FY2009$8.55B+0.9%
- FY2008$8.48B-1.7%
- FY2007$8.63B+0.9%
- FY2006$8.55B+2.2%
- FY2005$8.37B-8.7%
- FY2004$9.17B-3.6%
- FY2003$9.5B+373.5%
- FY2002$2.01B+16.6%
- FY2001$1.72B+20.2%
- FY2000$1.43B+12.0%
- FY1999$1.28B+38.2%
- FY1998$925M+13.6%
- FY1997$814M+28.2%
- FY1996$635M+35.2%
- FY1995$469M+24.2%
- FY1994$378M+5.8%
- FY1993$357M+14.7%
- FY1992$311M+23.0%
- FY1991$253M+59.7%
- FY1990$159M+9.2%
- FY1989$145M+79.5%
- FY1988$80.9M+0.2%
- FY1987$80.7M-20.0%
- FY1986$101M+17.6%
- FY1985$85.8M—
Total Assets values are taken from Biogen's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported total assets is $32.1B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Biogen (BIIB) total assets totalled $29.4B – edged up 5.0% year-over-year.
Over 2020–2025 (5 years), Biogen total assets expanded at a +3.6% compound annual rate, sustaining 4 straight years of year-over-year growth.
2025 marks the peak total assets at $29.4B, with the historical low of $80.7M recorded in 1987.
Biogen Total Assets by Year
Biogen Total Assets 2025: $29.4B
In 2025, Biogen reported total assets of $29.4B, edged up 5.0% from 2024. This figure represents the highest annual value in the available history.
Biogen Total Assets 2024: $28B
Biogen total assets in 2024 was $28B, edged up 4.5% from 2023.
Biogen Total Assets 2023: $26.8B
2023's total assets for Biogen came in at $26.8B, grew 9.3% from 2022.
Biogen Total Assets 2022: $24.6B
Biogen posted total assets of $24.6B in 2022, edged up 2.8% from 2021.
Biogen Total Assets 2021: $23.9B
Biogen total assets in 2021 was $23.9B.
See more financial history for Biogen (BIIB).
Sector peers by Total Assets
Healthcare peers of Biogen (BIIB), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on BIIB
Market Cap — 10 rounds, every one of them BIIB against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.